PuSH - Publication Server of Helmholtz Zentrum München

57 Records found.
Zum Exportieren der Ergebnisse bitte einloggen.
Lay all publications on this page into basket
21.
Endesfelder, D. et al.: A novel approach for the analysis of longitudinal profiles reveals delayed progression to type 1 diabetes in a subgroup of multiple-islet-autoantibody-positive children. Diabetologia 59, 2172-2180 (2016)
22.
Long, A.E.* et al.: Is there regulation of the autoimmune response in slow progressors to type 1 diabetes? Diabetic Med. 33, 76-77 (2016)
23.
Puff, R. et al.: [Early diagnosis, early care - "Fr1da" screening of children for type 1 diabetes]. MMW-Fortschr. Med. 158, 65-67 (2016)
24.
Raab, J. et al.: Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: Design and initial results of the Fr1da study. BMJ Open 6:e011144 (2016)
25.
Serr, I. et al.: Type 1 diabetes vaccine candidates promote human Foxp3+Treg induction in humanized mice. Nat. Commun. 7:10991 (2016)
26.
Ziegler, A.-G. et al.: 3 screen ELISA for high-throughput detection of beta cell autoantibodies in capillary blood. Diabetes Technol. Ther. 18, 687-693 (2016)
27.
Zillmer, S. et al.: Kinder mit Frühstadium des Typ-1-Diabetes: Drei Fallberichte aus der Fr1da-Studie. Diabetes Stoffwechs. Herz 25, 79-83 (2016)
28.
Bonifacio, E. et al.: Effects of high-dose oral insulin on immune responses in children at high risk for type 1 diabetes: The Pre-POINT randomized clinical trial. JAMA 313, 1541-1549 (2015)
29.
Chmiel, R. et al.: Progression from single to multiple islet autoantibodies often occurs soon after seroconversion: Implications for early screening. Diabetologia 58, 411-413 (2015)
30.
Giannopoulou, E.Z. et al.: Islet autoantibody phenotypes and incidence in children at increased risk for type 1 diabetes. Diabetologia 58, 2317-2323 (2015)
31.
Williams, A.J.* et al.: Detection of antibodies directed to the N-terminal region of GAD is dependent on assay format and contributes to differences in the specificity of GAD autoantibody assays for type 1 diabetes. Diabetes 64, 3239-3246 (2015)
32.
Williams, A.J.* et al.: Reactivity to N-terminally truncated GAD65(96-585) identifies GAD autoantibodies that are more closely associated with diabetes progression in relatives of patients with type 1 diabetes. Diabetes 64, 3247-3252 (2015)
33.
Achenbach, P. ; Winkler, C. ; Haupt, F. ; Beyerlein, A. & Ziegler, A.-G.: Prädisposition, frühe Stadien und Phänotypen des Typ-1-Diabetes. Dtsch. Med. Wochenschr. 139, 1100-1104 (2014)
34.
Achenbach, P. & Ziegler, A.-G.: Über Phänotypen des Diabetes mellitus und deren klinische Bedeutung. Dtsch. Med. Wochenschr. 139, 1095-1096 (2014)
35.
Bender, C.* ; Schlosser, M.* ; Christen, U.* ; Ziegler, A.-G. & Achenbach, P.: GAD autoantibody affinity in schoolchildren from the general population. Diabetologia 57, 1911-1918 (2014)
36.
Endesfelder, D. et al.: Compromised gut microbiota networks in children with anti-islet cell autoimmunity. Diabetes 63, 2006-2014 (2014)
37.
Ferreira, R.C.* et al.: A type I interferon transcriptional signature precedes autoimmunity in children genetically at risk of type 1 diabetes. Diabetes 63, 2538-2550 (2014)
38.
Krause, S. et al.: GAD autoantibody affinity in adult patients with latent autoimmune diabetes, the study participants of a GAD65 vaccination trial. Diabetes Care 37, 1675-1680 (2014)
39.
Krause, S. et al.: Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes. Acta Diabetol. 51, 517-518 (2014)
40.
Schlosser, M.* et al.: Combined appearance of autoantibodies against GAD, IA-2, insulin and ZnT8 in the islet autoantibody standardisation program 2013 proficiency workshop. Diabetologia 57, S145 (2014)